首页 › 基金 › SUPERSTRING CAPITAL MANAGEMENT LP › ORIC
SUPERSTRING CAPITAL MANAGEMENT LP 对 ORIC 的持仓历史
ORIC PHARMACEUTICALS INC · 医疗保健
SUPERSTRING CAPITAL MANAGEMENT LP 在 Q2 2026 的 13F 申报中披露持有 ORIC(ORIC PHARMACEUTICALS INC)406,077 股,市值约 US$4.4M,约占其申报组合的 2.78%,在其申报持仓中市值排名第 15 位。 SUPERSTRING CAPITAL MANAGEMENT LP 最近 8 个申报季度中有 8 个季度披露了 ORIC 持仓,最早可追溯至 Q3 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
SUPERSTRING CAPITAL MANAGEMENT LP 对 ORIC 的持仓演变
SUPERSTRING CAPITAL MANAGEMENT LP 于 Q3 2024 首次披露 ORIC 持仓:949,522 股(约 US$9.7M)。 在 8 次申报中,SUPERSTRING CAPITAL MANAGEMENT LP 3 次增持、4 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 406,077 股、市值约 US$4.4M,环比增持 290,843 股。。 持仓曾出现大幅变动:Q1 2025 增持约 310% (随后一个季度股价上涨 82%)、Q4 2025 增持约 186% (随后一个季度股价上涨 55%)、Q2 2026 增持约 252% (随后一个季度股价上涨 24%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2024 | 949.52K | $9.73M | 新进 |
| Q4 2024 | 200.00K | $1.61M | 减持 |
| Q1 2025 | 819.19K | $4.57M | 增持 |
| Q2 2025 | 344.92K | $3.50M | 减持 |
| Q3 2025 | 89.35K | $1.07M | 减持 |
| Q4 2025 | 255.37K | $2.09M | 增持 |
| Q1 2026 | 115.23K | $1.46M | 减持 |
| Q2 2026 | 406.08K | $4.40M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ORIC 与 13F 数据
ORIC(ORIC PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 41 只申报持有 ORIC,申报仓位最大的包括:Nextech Invest Ltd. (US$77.6M), EcoR1 Capital, LLC (US$72.9M), SR ONE CAPITAL MANAGEMENT, LP (US$50.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ORIC 的基金
- Nextech Invest Ltd. 7.16M 股 · $77.57M · Q2 2026
- EcoR1 Capital, LLC 6.73M 股 · $72.87M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 4.62M 股 · $49.98M · Q2 2026
- Venrock Adviser, LLC 4.32M 股 · $46.78M · Q2 2026
- NEA Management Company, LLC 4.12M 股 · $44.60M · Q2 2026
- AIHC Capital Management Ltd 3.83M 股 · $41.46M · Q2 2026
- Column Group LLC 3.54M 股 · $38.35M · Q2 2026
- Siren, L.L.C. 3.00M 股 · $32.47M · Q2 2026
- First Turn Management, LLC 2.02M 股 · $21.85M · Q2 2026
- Integral Health Asset Management, LLC 1.90M 股 · $20.58M · Q2 2026
- MPM BioImpact LLC 1.88M 股 · $20.38M · Q2 2026
- Vivo Capital, LLC 1.85M 股 · $20.02M · Q2 2026
更多关于 SUPERSTRING CAPITAL MANAGEMENT LP
常见问题
How long has SUPERSTRING CAPITAL MANAGEMENT LP held ORIC?
SUPERSTRING CAPITAL MANAGEMENT LP has disclosed ORIC holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in ORIC?
As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 406.08K shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $4.40M, representing 2.78% of its reported portfolio and ranking #15.
Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling ORIC?
In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP increased its position in ORIC.
Which other funds hold ORIC?
Other major institutional holders of ORIC include Nextech Invest Ltd., EcoR1 Capital, LLC, SR ONE CAPITAL MANAGEMENT, LP, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.